Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
genentech
6
×
life sciences
national blog main
6
×
national top stories
san francisco top stories
boston blog main
boston top stories
san francisco blog main
eli lilly
indiana blog main
indiana top stories
national
new york top stories
roche
boulder/denver blog main
boulder/denver top stories
cancer
celgene
clinical trials
deals
detroit blog main
detroit top stories
fda
investing
new york blog main
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
agenus
avapritinib
What
drug
6
×
fda
approved
bio
roundup
approval
blueprint
cancer
companies
latest
medicines
news
ret
roche
therapy
address
adu
alzheimer’s
approves
atrophy
beats
bids
biogen
candidate
carries
certain
complicated
currently
daily
depression
designed
different
digital
dire
disease
epidemic
evrysdi
fail
fatty
frenzied
Language
unset
Current search:
genentech
×
biotech
×
drug
×
" national blog main "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More